NCT03604653View on ClinicalTrials.gov

Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Stomach CancerColorectal CancerAppendiceal CancerOvarian CancerUterine CancerCervical CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Interventions
DEVICE

HIPEC

Heated chemotherapy is pumped into the abdomen and circulated for 90 minutes

DRUG

Mitomycin c

MMC 30mg@ T0, 10mg@T45 min

DRUG

CDDP 50

50mg/m2@T0

DRUG

CDDP 75

75mg/m2@T0

DRUG

Doxorubicin

15mg/m2@T0

Trial Locations (1)

07666

Holy Name Medical Center, Teaneck

All Listed Sponsors
lead

Holy Name Medical Center, Inc.

OTHER

NCT03604653 - Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | Biotech Hunter | Biotech Hunter